FDA批准首个生物仿制药Zarxio（诺华公司）用于化疗后升白细胞的药物

FDA批准诺华旗下山多士（Sandoz）公司生产的首个生物仿制药Zarxio（廉价版，欧洲商品名：Zarzio，was approved in Europe in 2009 as Zarzio）上市。用于治疗原研药Neupogen（Amgen，安进公司）批准的所有五个适应症。

http://mobile./2015/03/07/health/fda-approves-zarxio-first-biosimilar-drug.html?referrer=

Biosimilar drugs, which could replace some costly remedies, being made at a Novartis plant.

A lower-cost version of the Amgen biologic drug Neupogen, used in cancer treatment,
could open the door to more such biosimilar medicines.